Gene: PRICKLE1
Official Full Name: prickle planar cell polarity protein 1provided by HGNC
Gene Summary: This gene encodes a nuclear receptor that may be a negative regulator of the Wnt/beta-catenin signaling pathway. The encoded protein localizes to the nuclear membrane and has been implicated in the nuclear trafficking of the transcription repressors REST/NRSF and REST4. Mutations in this gene have been linked to progressive myoclonus epilepsy. Alternate splicing results in multiple transcript variants. A pseudogene of this gene is found on chromosome 3. [provided by RefSeq, Sep 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO01397 | PRICKLE1 Knockout cell line (HeLa) | Human | PRICKLE1 | 1:3~1:6 | Negative | Online Inquiry |
KO11703 | PRICKLE1 Knockout cell line (HCT 116) | Human | PRICKLE1 | 1:2~1:4 | Negative | Online Inquiry |
KO11704 | PRICKLE1 Knockout cell line (HEK293) | Human | PRICKLE1 | 1:3~1:6 | Negative | Online Inquiry |
PRICKLE1 Gene Knockout Cell Lines are a sophisticated tool designed for biological research, aimed at elucidating the functional roles of the PRICKLE1 gene, which is pivotal in cellular processes including signal transduction and cellular polarity. These knockout cell lines are engineered through CRISPR-Cas9 technology to ensure a complete disruption of the PRICKLE1 gene, allowing researchers to study the resultant phenotypic and molecular changes in cellular behavior.
The primary mechanism by which PRICKLE1 Gene Knockout Cell Lines operate is through the targeted deletion of the PRICKLE1 gene, resulting in the loss of its protein product. This knockout approach enables scientists to investigate the downstream effects of PRICKLE1 on Wnt signaling pathways, neural development, and cell morphology, thereby providing insights into its role in diseases where these pathways play critical roles, such as cancer and neurodevelopmental disorders.
The scientific significance and applications of these cell lines extend into both research and clinical settings. They serve as vital models for studying atypical cell behaviors compared to wild-type cells, facilitating drug discovery, genetic analysis, and understanding pathophysiological mechanisms associated with PRICKLE1 deficiency. Researchers can utilize these cell lines to screen for therapeutic compounds, assess gene function, or investigate genetic interactions in complex disease models.
When compared to alternative models that may provide incomplete insights, PRICKLE1 Gene Knockout Cell Lines offer specific advantages, including reproducibility, high-throughput screening capabilities, and adaptability for various experimental designs. Their utilization can greatly enhance the understanding of PRICKLE1-related pathways, creating a more efficient research landscape.
For researchers, clinicians, and biotechnology professionals, the value of PRICKLE1 Gene Knockout Cell Lines lies in their ability to foster innovative discoveries and therapeutic advancements. By utilizing these specialized cell lines, users can gain a profound understanding of molecular mechanisms, ultimately paving the way for new treatments.
At [Company Name], we pride ourselves on our expertise in the development of precise biological tools, ensuring our products meet the highest standards of quality and innovation to support groundbreaking research in various biological fields.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.